Finland

7.1.2022

What guidelines do clinicians follow for breast contouring?

According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…

News

5.11.2021

YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals

Helsinki - 5th of November, 2021 - MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in…

Press Releases

14.9.2021

Docrates, the Leading Finnish Cancer Center that Enabled the Same-Day Treatment Program with MVision AI

About the client Docrates is a Finnish private hospital, providing high-quality and prompt cancer care with the latest technologies. Operating for almost 15 years, Docrates’ network of oncological experts has extensive knowledge of the diagnosis and treatment of various cancers. Docrates helps over 1500 cancer patients annually. 30% of Docrates’…

News

8.7.2021

New Partnership in Switzerland

Helsinki – July 8, 2021 – MVision AI, the cloud-based software service provider for radiotherapy treatment planning, today announces that the company has entered into a distribution partnership agreement with the Swiss provider of products and services for optimization of medical equipment, intellimed. Together, intellimed and MVision AI will work…

News, Press Releases

14.6.2021

New Partnership in the UK and Ireland

Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing MVision AI’s high-quality, segmentation services throughout the UK and Ireland region. (more…)

News, Press Releases

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI